<SEC-DOCUMENT>0001206774-15-003411.txt : 20151109
<SEC-HEADER>0001206774-15-003411.hdr.sgml : 20151109
<ACCEPTANCE-DATETIME>20151105161024
ACCESSION NUMBER:		0001206774-15-003411
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20151105
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20151105
DATE AS OF CHANGE:		20151105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GERON CORP
		CENTRAL INDEX KEY:			0000886744
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				752287752
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20859
		FILM NUMBER:		151200721

	BUSINESS ADDRESS:	
		STREET 1:		149 COMMONWEALTH DRIVE
		STREET 2:		SUITE 2070
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		6504737700

	MAIL ADDRESS:	
		STREET 1:		149 COMMONWEALTH DRIVE
		STREET 2:		SUITE 2070
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GERON CORPORATION
		DATE OF NAME CHANGE:	19960521
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>geron_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=center><B><FONT face="Times New Roman" size=2>UNITED STATES
<BR></FONT></B><B><FONT face="Times New Roman" size=2>SECURITIES AND EXCHANGE
COMMISSION<BR>WASHINGTON, D.C. 20549 <BR>___________<BR></FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>FORM 8-K </FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>CURRENT
REPORT<BR></FONT></B><B><FONT face="Times New Roman" size=2>PURSUANT TO SECTION
13 OR 15(d) OF THE<BR>SECURITIES EXCHANGE ACT OF 1934</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>Date of Report (Date of
earliest event reported): </FONT><B><FONT face="Times New Roman" size=2>November
5, 2015</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2>GERON
CORPORATION</FONT></B><FONT face="Times New Roman" size=2> <BR></FONT><FONT face="Times New Roman" size=2>(Exact name of registrant as specified in its
charter) </FONT></P>
<TABLE style="LINE-HEIGHT: NORMAL; BORDER-COLLAPSE: collapse" cellSpacing=1 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap style="text-align: center" width="32%"><B><FONT face="Times New Roman" size=2>Delaware</FONT></B></TD>
    <TD noWrap style="text-align: center" width="40%"><B><FONT face="Times New Roman" size=2>0-20859</FONT></B></TD>
    <TD noWrap style="text-align: center" width="27%"><B><FONT face="Times New Roman" size=2>75-2287752</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap style="text-align: center" width="32%"><FONT face="Times New Roman" size=2>(State or other jurisdiction</FONT></TD>
    <TD noWrap style="text-align: center" width="40%"><FONT face="Times New Roman" size=2>(Commission File Number)</FONT></TD>
    <TD noWrap style="text-align: center" width="27%"><FONT face="Times New Roman" size=2>(IRS
      Employer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap style="text-align: center" width="32%"><FONT face="Times New Roman" size=2>of
      incorporation)</FONT></TD>
    <TD noWrap style="text-align: center" width="40%"></TD>
    <TD noWrap style="text-align: center" width="27%"><FONT face="Times New Roman" size=2>Identification
No.)</FONT></TD></TR></TABLE><BR>
<P align=center><B><FONT face="Times New Roman" size=2>149 COMMONWEALTH DRIVE,
SUITE 2070<BR>MENLO PARK, CALIFORNIA 94025 <BR></FONT></B><FONT face="Times New Roman" size=2>(Address of principal executive offices, including
zip code) </FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2>(650)
473-7700<BR></FONT></B><FONT face="Times New Roman" size=2>(Registrant&#146;s
telephone number, including area code) </FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2>N/A <BR></FONT></B><FONT face="Times New Roman" size=2>(Former name or former address, if changed since
last report) </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions: </FONT></P>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt" vAlign=top align=left width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9744;</FONT></TD>
    <TD vAlign=top align=left width="99%">Written communications pursuant to
      Rule 425 under the Securities Act (17 CFR 230.425) <BR>&nbsp;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt" vAlign=top align=left width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9744;</FONT></TD>
    <TD vAlign=top align=left width="99%">Soliciting material pursuant to Rule
      14a-12 under the Exchange Act (17 CFR 240.14a-12) <BR>&nbsp;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt" vAlign=top align=left width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9744;</FONT></TD>
    <TD vAlign=top align=left width="99%">Pre-commencement communications
      pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR <FONT face="Times New Roman" size=2>240.14d-2(b))</FONT> <BR>&nbsp;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt" vAlign=top align=left width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9744;</FONT></TD>
    <TD vAlign=top align=left width="99%">Pre-commencement communications
      pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR <FONT face="Times New Roman" size=2>240.13e-4(c))</FONT>
</TD></TR></TABLE><BR>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>Item 2.02 Results of
Operations and Financial Condition </FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Geron Corporation (the
&#147;Company&#148;) is furnishing this information under Item 2.02 of Form 8-K.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The information in this
Current Report, including Exhibit 99.1, is being furnished and shall not be
deemed &#147;filed&#148; for the purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the &#147;Exchange Act&#148;), or otherwise subject to the liabilities
of that section. The information in this Current Report, including Exhibit 99.1,
shall not be incorporated by reference into any registration statement or other
document filed pursuant to the Securities Act of 1933, as amended, or the
Exchange Act. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>On November 5, 2015, the
Company issued a press release announcing its financial results for the three
and nine months ended September 30, 2015. A copy of the press release is
attached as Exhibit 99.1. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Item 9.01 Financial
Statements and Exhibits</FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(d) Exhibits </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><STRONG><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></STRONG></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><B><FONT face="Times New Roman" size=2>Exhibit No.</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><STRONG><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></STRONG></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="96%"><B><FONT face="Times New Roman" size=2>Description</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="1%" bgColor=#cceeff><FONT face="Times New Roman" size=2>99.1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff>&nbsp;</TD>
    <TD noWrap align=left width="96%" bgColor=#cceeff><FONT face="Times New Roman" size=2>Press release dated November 5,
  2015.</FONT></TD></TR></TABLE><BR>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>SIGNATURE </FONT></B></P>
<P ALIGN="JUSTIFY" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized. </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=1 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="50%" colSpan=2>&nbsp;</TD>
    <TD noWrap align=left width="49%" colSpan=3><FONT face="Times New Roman" size=2>GERON CORPORATION</FONT></TD></TR>
  <TR>
    <TD width="99%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD width="99%" colSpan=5>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Date:&nbsp;</FONT></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>November 5, 2015</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>By:</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="24%"><FONT face="Times New Roman" size=2>/s/ Stephen N.
Rosenfield</FONT></TD>
    <TD noWrap align=left width="24%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Name:&nbsp; </FONT></TD>
    <TD noWrap align=left width="48%" colSpan=2><FONT face="Times New Roman" size=2>Stephen N. Rosenfield</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Title:</FONT></TD>
    <TD noWrap align=left width="48%" colSpan=2><FONT face="Times New Roman" size=2>Executive Vice President, General Counsel and</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=left width="48%" colSpan=2><FONT face="Times New Roman" size=2>Corporate Secretary</FONT></TD></TR></TABLE><BR>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>EXHIBIT INDEX
</FONT></B></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="1%"><FONT face="Times New Roman" size=2>Exhibit No.</FONT></TD>
    <TD noWrap align=left width="1%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Description</FONT></TD>
    <TD noWrap align=left width="97%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap style="text-align: center" width="1%" bgColor=#cceeff><FONT face="Times New Roman" size=2>99.1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff>&nbsp;</TD>
    <TD noWrap align=left width="98%" bgColor=#cceeff colSpan=2><FONT face="Times New Roman" size=2>Press release dated November 5,
  2015.</FONT></TD></TR></TABLE><BR>
<HR align=center width="100%" noShade SIZE=2>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>PRESS RELEASE DATED NOVEMBER 5, 2015
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor="#ffffff">

<BR>
<P align=right><STRONG><FONT face="Times New Roman" size=2>EXHIBIT 99.1
</FONT><FONT face="Times New Roman" size=2></FONT></STRONG></P>
<P align=center><STRONG><FONT face="Times New Roman" size=2>Press Release Dated
November 5, 2015</FONT><FONT face="Times New Roman" size=2></FONT></STRONG></P><STRONG><IMG src="exhibit99-1x1x1.jpg" border=0>
<BR></STRONG>
<P align=center><STRONG><FONT face="Times New Roman" size=2>Geron Corporation
Reports Third Quarter 2015 Financial Results</FONT><FONT face="Times New Roman" size=2></FONT></STRONG></P>
<P align=left><FONT face="Times New Roman" size=2><STRONG>MENLO PARK, Calif.,  November 5, 2015</STRONG>&nbsp;--</FONT><FONT face="Times New Roman" size=2>
</FONT><FONT face="Times New Roman" size=2>Geron Co</FONT><FONT face="Times New Roman" size=2>r</FONT><FONT face="Times New Roman" size=2>poration
(Nas</FONT><FONT face="Times New Roman" size=2>d</FONT><FONT face="Times New Roman" size=2>aq: GERN) to</FONT><FONT face="Times New Roman" size=2>d</FONT><FONT face="Times New Roman" size=2>ay
reported </FONT><FONT face="Times New Roman" size=2>f</FONT><FONT face="Times New Roman" size=2>inancial results for </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>the
third quarter ended  </FONT><FONT face="Times New Roman" size=2>S</FONT><FONT face="Times New Roman" size=2>eptember
30</FONT><FONT face="Times New Roman" size=2>, </FONT><FONT face="Times New Roman" size=2>2015.</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>For the third quarter of  </FONT><FONT face="Times New Roman" size=2>2</FONT><FONT face="Times New Roman" size=2>015,
the com</FONT><FONT face="Times New Roman" size=2>p</FONT><FONT face="Times New Roman" size=2>any reported net
income o</FONT><FONT face="Times New Roman" size=2>f </FONT><FONT face="Times New Roman" size=2>$27.2  million</FONT><FONT face="Times New Roman" size=2>, </FONT><FONT face="Times New Roman" size=2>or
$0.17 per </FONT><FONT face="Times New Roman" size=2>s</FONT><FONT face="Times New Roman" size=2>hare, compared to </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>a
net  loss </FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>f $9.5 million</FONT><FONT face="Times New Roman" size=2>, </FONT><FONT face="Times New Roman" size=2>or
$(0.06) pe</FONT><FONT face="Times New Roman" size=2>r </FONT><FONT face="Times New Roman" size=2>share, for th</FONT><FONT face="Times New Roman" size=2>e </FONT><FONT face="Times New Roman" size=2>comparable </FONT><FONT face="Times New Roman" size=2>2</FONT><FONT face="Times New Roman" size=2>014
period. </FONT><FONT face="Times New Roman" size=2>N</FONT><FONT face="Times New Roman" size=2>et  income for the
first nine </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>months of 2015 was
$8.</FONT><FONT face="Times New Roman" size=2>5 </FONT><FONT face="Times New Roman" size=2>million, or $</FONT><FONT face="Times New Roman" size=2>0</FONT><FONT face="Times New Roman" size=2>.05
per share, compared to </FONT><FONT face="Times New Roman" size=2>a </FONT><FONT face="Times New Roman" size=2>net loss of
$</FONT><FONT face="Times New Roman" size=2>2</FONT><FONT face="Times New Roman" size=2>6.7 million, or $(0.18)
per s</FONT><FONT face="Times New Roman" size=2>h</FONT><FONT face="Times New Roman" size=2>are, </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>for
the co</FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>parable 201</FONT><FONT face="Times New Roman" size=2>4 </FONT><FONT face="Times New Roman" size=2>period.
The c</FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>mpany ende</FONT><FONT face="Times New Roman" size=2>d </FONT><FONT face="Times New Roman" size=2>the
third qu</FONT><FONT face="Times New Roman" size=2>a</FONT><FONT face="Times New Roman" size=2>rter  of 2015 </FONT><FONT face="Times New Roman" size=2>w</FONT><FONT face="Times New Roman" size=2>ith
$151.8 mi</FONT><FONT face="Times New Roman" size=2>l</FONT><FONT face="Times New Roman" size=2>lion in cash a</FONT><FONT face="Times New Roman" size=2>n</FONT><FONT face="Times New Roman" size=2>d </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>investments.</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Revenues </FONT><FONT face="Times New Roman" size=2>f</FONT><FONT face="Times New Roman" size=2>or
the  third q</FONT><FONT face="Times New Roman" size=2>u</FONT><FONT face="Times New Roman" size=2>arter of 2015 were $35.4 </FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>illion
compar</FONT><FONT face="Times New Roman" size=2>e</FONT><FONT face="Times New Roman" size=2>d to $160,00</FONT><FONT face="Times New Roman" size=2>0 </FONT><FONT face="Times New Roman" size=2>for
the comp</FONT><FONT face="Times New Roman" size=2>a</FONT><FONT face="Times New Roman" size=2>rable  2014 p</FONT><FONT face="Times New Roman" size=2>e</FONT><FONT face="Times New Roman" size=2>riod. </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>Revenues </FONT><FONT face="Times New Roman" size=2>f</FONT><FONT face="Times New Roman" size=2>or
the  first ni</FONT><FONT face="Times New Roman" size=2>n</FONT><FONT face="Times New Roman" size=2>e months of </FONT><FONT face="Times New Roman" size=2>2</FONT><FONT face="Times New Roman" size=2>015
were $36.2 million compared to $97</FONT><FONT face="Times New Roman" size=2>5</FONT><FONT face="Times New Roman" size=2>,000
for the c</FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>mparable 20</FONT><FONT face="Times New Roman" size=2>1</FONT><FONT face="Times New Roman" size=2>4 </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>period.
Re</FONT><FONT face="Times New Roman" size=2>v</FONT><FONT face="Times New Roman" size=2>enues for th</FONT><FONT face="Times New Roman" size=2>e </FONT><FONT face="Times New Roman" size=2>three
and nine month peri</FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>ds ending September
30, 2</FONT><FONT face="Times New Roman" size=2>0</FONT><FONT face="Times New Roman" size=2>15 included t</FONT><FONT face="Times New Roman" size=2>h</FONT><FONT face="Times New Roman" size=2>e
full recogni</FONT><FONT face="Times New Roman" size=2>t</FONT><FONT face="Times New Roman" size=2>ion of </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>the
$35.0 </FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>illion upfron</FONT><FONT face="Times New Roman" size=2>t </FONT><FONT face="Times New Roman" size=2>payment
fro</FONT><FONT face="Times New Roman" size=2>m </FONT><FONT face="Times New Roman" size=2>Janssen Biotech, Inc.
(Jans</FONT><FONT face="Times New Roman" size=2>sen) </FONT><FONT face="Times New Roman" size=2>as collab</FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>ration
revenue upon the </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>company&#146;</FONT><FONT face="Times New Roman" size=2>s </FONT><FONT face="Times New Roman" size=2>transfer
of the imetelstat  li</FONT><FONT face="Times New Roman" size=2>c</FONT><FONT face="Times New Roman" size=2>ense rights
a</FONT><FONT face="Times New Roman" size=2>n</FONT><FONT face="Times New Roman" size=2>d completion of technology
transfer</FONT><FONT face="Times New Roman" size=2>-</FONT><FONT face="Times New Roman" size=2>relat</FONT><FONT face="Times New Roman" size=2>e</FONT><FONT face="Times New Roman" size=2>d
activities</FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2> outlined under the
imet</FONT><FONT face="Times New Roman" size=2>e</FONT><FONT face="Times New Roman" size=2>lstat collabor</FONT><FONT face="Times New Roman" size=2>a</FONT><FONT face="Times New Roman" size=2>tion
agreement with Janssen. The upfron</FONT><FONT face="Times New Roman" size=2>t  </FONT><FONT face="Times New Roman" size=2>cash
payment was receive</FONT><FONT face="Times New Roman" size=2>d </FONT><FONT face="Times New Roman" size=2>in </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>December
2014 and rec</FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>rded  as deferred revenue
a</FONT><FONT face="Times New Roman" size=2>t </FONT><FONT face="Times New Roman" size=2>that time.</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Total operating  expense</FONT><FONT face="Times New Roman" size=2>s </FONT><FONT face="Times New Roman" size=2>for
the third </FONT><FONT face="Times New Roman" size=2>q</FONT><FONT face="Times New Roman" size=2>uarter of 20</FONT><FONT face="Times New Roman" size=2>1</FONT><FONT face="Times New Roman" size=2>5
were  $8.3 </FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>illion compar</FONT><FONT face="Times New Roman" size=2>e</FONT><FONT face="Times New Roman" size=2>d
to $10.1 million for  the </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>comparab</FONT><FONT face="Times New Roman" size=2>l</FONT><FONT face="Times New Roman" size=2>e
2014 period. Research  an</FONT><FONT face="Times New Roman" size=2>d </FONT><FONT face="Times New Roman" size=2>developmen</FONT><FONT face="Times New Roman" size=2>t </FONT><FONT face="Times New Roman" size=2>expenses
for the third quarter of 2015 w</FONT><FONT face="Times New Roman" size=2>e</FONT><FONT face="Times New Roman" size=2>re
$4.1 millio</FONT><FONT face="Times New Roman" size=2>n</FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>
compared to $6.0 millio</FONT><FONT face="Times New Roman" size=2>n </FONT><FONT face="Times New Roman" size=2>for
the comparable 2014 p</FONT><FONT face="Times New Roman" size=2>e</FONT><FONT face="Times New Roman" size=2>riod. General
and administ</FONT><FONT face="Times New Roman" size=2>r</FONT><FONT face="Times New Roman" size=2>ative  expenses for the
third quarter of 2015 were $4.3 million compared to $4.1  </FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>illion
for the comparable </FONT><FONT face="Times New Roman" size=2>2</FONT><FONT face="Times New Roman" size=2>014
period.</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Total operating  expense</FONT><FONT face="Times New Roman" size=2>s </FONT><FONT face="Times New Roman" size=2>for
the first </FONT><FONT face="Times New Roman" size=2>n</FONT><FONT face="Times New Roman" size=2>ine months o</FONT><FONT face="Times New Roman" size=2>f </FONT><FONT face="Times New Roman" size=2>2015
were $</FONT><FONT face="Times New Roman" size=2>2</FONT><FONT face="Times New Roman" size=2>8.1 million co</FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>pared
to $2</FONT><FONT face="Times New Roman" size=2>8</FONT><FONT face="Times New Roman" size=2>.3  million for </FONT><FONT face="Times New Roman" size=2>t</FONT><FONT face="Times New Roman" size=2>he</FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>
comparab</FONT><FONT face="Times New Roman" size=2>l</FONT><FONT face="Times New Roman" size=2>e 2014  period. Research
an</FONT><FONT face="Times New Roman" size=2>d </FONT><FONT face="Times New Roman" size=2>developmen</FONT><FONT face="Times New Roman" size=2>t </FONT><FONT face="Times New Roman" size=2>expenses
for the first nine  </FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>onths of 2015
were $13.8 </FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>illion </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>compared
to $16.4 milli</FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>n for the
comparable 2014  </FONT><FONT face="Times New Roman" size=2>p</FONT><FONT face="Times New Roman" size=2>eriod.
Gener</FONT><FONT face="Times New Roman" size=2>a</FONT><FONT face="Times New Roman" size=2>l and adminis</FONT><FONT face="Times New Roman" size=2>t</FONT><FONT face="Times New Roman" size=2>rative
expenses for the first  nine</FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2> months of
2015 were $12.9 million co</FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>pared  to
$11.9 million for the comparabl</FONT><FONT face="Times New Roman" size=2>e  </FONT><FONT face="Times New Roman" size=2>2014
period</FONT><FONT face="Times New Roman" size=2>. </FONT><FONT face="Times New Roman" size=2>Year-to</FONT><FONT face="Times New Roman" size=2>-</FONT><FONT face="Times New Roman" size=2>date </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>operating </FONT><FONT face="Times New Roman" size=2>e</FONT><FONT face="Times New Roman" size=2>xpenses
for </FONT><FONT face="Times New Roman" size=2>2</FONT><FONT face="Times New Roman" size=2>015 also inclu</FONT><FONT face="Times New Roman" size=2>d</FONT><FONT face="Times New Roman" size=2>ed
restructu</FONT><FONT face="Times New Roman" size=2>r</FONT><FONT face="Times New Roman" size=2>ing  charges of $1.3
million i</FONT><FONT face="Times New Roman" size=2>n  </FONT><FONT face="Times New Roman" size=2>connection </FONT><FONT face="Times New Roman" size=2>w</FONT><FONT face="Times New Roman" size=2>ith
the comp</FONT><FONT face="Times New Roman" size=2>a</FONT><FONT face="Times New Roman" size=2>ny&#146;s </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>organizati</FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>nal
resizing a</FONT><FONT face="Times New Roman" size=2>n</FONT><FONT face="Times New Roman" size=2>nounced in </FONT><FONT face="Times New Roman" size=2>M</FONT><FONT face="Times New Roman" size=2>arch
2015.</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The decre</FONT><FONT face="Times New Roman" size=2>a</FONT><FONT face="Times New Roman" size=2>se
in  researc</FONT><FONT face="Times New Roman" size=2>h </FONT><FONT face="Times New Roman" size=2>and develop</FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>ent
expense</FONT><FONT face="Times New Roman" size=2>s </FONT><FONT face="Times New Roman" size=2>for  the three and
nine mon</FONT><FONT face="Times New Roman" size=2>t</FONT><FONT face="Times New Roman" size=2>h periods en</FONT><FONT face="Times New Roman" size=2>d</FONT><FONT face="Times New Roman" size=2>ing
September 30, </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>2015,  compared to
the same periods i</FONT><FONT face="Times New Roman" size=2>n  </FONT><FONT face="Times New Roman" size=2>2014, was
primarily the  ne</FONT><FONT face="Times New Roman" size=2>t </FONT><FONT face="Times New Roman" size=2>result of
low</FONT><FONT face="Times New Roman" size=2>e</FONT><FONT face="Times New Roman" size=2>r costs for th</FONT><FONT face="Times New Roman" size=2>e </FONT><FONT face="Times New Roman" size=2>manufacturi</FONT><FONT face="Times New Roman" size=2>n</FONT><FONT face="Times New Roman" size=2>g
of </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>imetelstat and reduced  </FONT><FONT face="Times New Roman" size=2>p</FONT><FONT face="Times New Roman" size=2>ersonnel-</FONT><FONT face="Times New Roman" size=2>rela</FONT><FONT face="Times New Roman" size=2>t</FONT><FONT face="Times New Roman" size=2>ed
costs resulting from the </FONT><FONT face="Times New Roman" size=2>organizational </FONT><FONT face="Times New Roman" size=2>resizing,
partially offset by </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>increased </FONT><FONT face="Times New Roman" size=2>c</FONT><FONT face="Times New Roman" size=2>osts
for the development  o</FONT><FONT face="Times New Roman" size=2>f </FONT><FONT face="Times New Roman" size=2>imetelstat
fo</FONT><FONT face="Times New Roman" size=2>r </FONT><FONT face="Times New Roman" size=2>hematologic myeloid malignancies in collaboration wit</FONT><FONT face="Times New Roman" size=2>h</FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>
Janssen. T</FONT><FONT face="Times New Roman" size=2>h</FONT><FONT face="Times New Roman" size=2>e company e</FONT><FONT face="Times New Roman" size=2>x</FONT><FONT face="Times New Roman" size=2>pects
research and development expenses to increase </FONT><FONT face="Times New Roman" size=2>d</FONT><FONT face="Times New Roman" size=2>uring
the remainder of the </FONT><FONT face="Times New Roman" size=2>y</FONT><FONT face="Times New Roman" size=2>ear </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>as
the dev</FONT><FONT face="Times New Roman" size=2>e</FONT><FONT face="Times New Roman" size=2>lopment of i</FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>etelstat
cont</FONT><FONT face="Times New Roman" size=2>i</FONT><FONT face="Times New Roman" size=2>nues in collab</FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>ration
with J</FONT><FONT face="Times New Roman" size=2>a</FONT><FONT face="Times New Roman" size=2>nssen. The in</FONT><FONT face="Times New Roman" size=2>c</FONT><FONT face="Times New Roman" size=2>rease
in general  and </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>administr</FONT><FONT face="Times New Roman" size=2>a</FONT><FONT face="Times New Roman" size=2>tive
expenses for the three  </FONT><FONT face="Times New Roman" size=2>a</FONT><FONT face="Times New Roman" size=2>nd nine
month periods end</FONT><FONT face="Times New Roman" size=2>i</FONT><FONT face="Times New Roman" size=2>ng
Septembe</FONT><FONT face="Times New Roman" size=2>r </FONT><FONT face="Times New Roman" size=2>30, 2015, co</FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>pared
to the </FONT><FONT face="Times New Roman" size=2>same </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>periods
in 2014, was pri</FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>arily
the res</FONT><FONT face="Times New Roman" size=2>u</FONT><FONT face="Times New Roman" size=2>lt of higher n</FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>n</FONT><FONT face="Times New Roman" size=2>-</FONT><FONT face="Times New Roman" size=2>cash
stock-</FONT><FONT face="Times New Roman" size=2>b</FONT><FONT face="Times New Roman" size=2>ased compen</FONT><FONT face="Times New Roman" size=2>sation </FONT><FONT face="Times New Roman" size=2>expens</FONT><FONT face="Times New Roman" size=2>e </FONT><FONT face="Times New Roman" size=2>and
increased </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>legal costs
associated wi</FONT><FONT size=2 face="Times New Roman">t</FONT><FONT face="Times New Roman" size=2>h the  compa</FONT><FONT face="Times New Roman" size=2>n</FONT><FONT face="Times New Roman" size=2>y&#146;s
patent po</FONT><FONT face="Times New Roman" size=2>r</FONT><FONT face="Times New Roman" size=2>tfolio.</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Interest a</FONT><FONT face="Times New Roman" size=2>n</FONT><FONT face="Times New Roman" size=2>d
other inco</FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>e for the thir</FONT><FONT face="Times New Roman" size=2>d </FONT><FONT face="Times New Roman" size=2>quarter
of 2015 amounted  </FONT><FONT face="Times New Roman" size=2>t</FONT><FONT face="Times New Roman" size=2>o $187,000
c</FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>mpared to $</FONT><FONT face="Times New Roman" size=2>9</FONT><FONT face="Times New Roman" size=2>1,000
for the</FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2> comparab</FONT><FONT face="Times New Roman" size=2>l</FONT><FONT face="Times New Roman" size=2>e
2014 period. Interest and </FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>ther  income </FONT><FONT face="Times New Roman" size=2>f</FONT><FONT face="Times New Roman" size=2>or
the first ni</FONT><FONT face="Times New Roman" size=2>n</FONT><FONT face="Times New Roman" size=2>e months of </FONT><FONT face="Times New Roman" size=2>2</FONT><FONT face="Times New Roman" size=2>015
was $48</FONT><FONT face="Times New Roman" size=2>1</FONT><FONT face="Times New Roman" size=2>,000 compared to </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>$273,000 </FONT><FONT face="Times New Roman" size=2>f</FONT><FONT face="Times New Roman" size=2>or
the compa</FONT><FONT face="Times New Roman" size=2>r</FONT><FONT face="Times New Roman" size=2>able 2014 pe</FONT><FONT face="Times New Roman" size=2>r</FONT><FONT face="Times New Roman" size=2>iod.
The incre</FONT><FONT face="Times New Roman" size=2>a</FONT><FONT face="Times New Roman" size=2>se in interest and other
inc</FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>me for  the three and nine </FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>onth</FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>
periods ending September 30,  2015, c</FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>mpared
to th</FONT><FONT face="Times New Roman" size=2>e </FONT><FONT face="Times New Roman" size=2>same period</FONT><FONT face="Times New Roman" size=2>s </FONT><FONT face="Times New Roman" size=2>in
2014, pri</FONT><FONT face="Times New Roman" size=2>m</FONT><FONT face="Times New Roman" size=2>arily reflects </FONT><FONT face="Times New Roman" size=2>h</FONT><FONT face="Times New Roman" size=2>igher
yields on  the</FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>
company&#146;</FONT><FONT face="Times New Roman" size=2>s </FONT><FONT face="Times New Roman" size=2>investment
portfolio. The  c</FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>mpany has
n</FONT><FONT face="Times New Roman" size=2>o</FONT><FONT face="Times New Roman" size=2>t incurred an</FONT><FONT face="Times New Roman" size=2>y </FONT><FONT face="Times New Roman" size=2>impairment </FONT><FONT face="Times New Roman" size=2>c</FONT><FONT face="Times New Roman" size=2>harges
on its investment </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>portfolio.</FONT><FONT face="Times New Roman" size=2></FONT></P><STRONG>
<HR align=center width="100%" noShade size="2">
</STRONG>
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>Recent Company
Events</FONT></B><B><FONT face="Times New Roman" size=2></FONT></B></P>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top align=left width="99%">Two papers were published in the
      September 3, 2015 issue of The New England Journal of Medicine (NEJM) with
      results from two clinical studies in which imetelstat was shown to have
      disease-modifying activity thought to be associated with the selective
      inhibition of the malignant progenitor cell clones responsible for the
      underlying disease in two hematologic myeloid malignancies, essential
      thrombocythemia (ET) and myelofibrosis (MF). The papers are available
      online at www.NEJM.org.<BR>&nbsp;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top align=left width="99%">In September 2015, the first patient
      was dosed in the IMbark&#153; study, a Phase 2 clinical trial to evaluate
      the activity of two dose levels of imetelstat in patients with DIPSS
      intermediate-2 or high-risk myelofibrosis who have relapsed after or are
      refractory to a JAK inhibitor. Multiple medical centers across North
      America, Europe and Asia are planned to participate in this clinical trial.
      For more information about the IMbark&#153; study being conducted by Janssen, please visit http://clinicaltrials.gov/ct2/show/NCT02426086.<BR>
&nbsp;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top align=left width="99%">Three abstracts describing clinical
      and non-clinical data on imetelstat were accepted for presentation at
      the 57th American Society of Hematology (ASH) Annual Meeting and Exposition
      to be held in Orlando, Florida from December 5-8, 2015. The abstracts were
      published on November 5, 2015 on the ASH website
  at www.hematology.org.</TD></TR></TABLE>
<P align=left><B><FONT face="Times New Roman" size=2>Conference
Call</FONT></B><B><FONT face="Times New Roman" size=2></FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>At 4:30 p.m. EST on November
5, 2015, Geron&#146;s management will host a conference call to discuss the
company&#146;s </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>third quarter financial results and recent
events.</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Participants can access the  conference call live via telephone by dialing
888</FONT><FONT face="Times New Roman" size=2>-</FONT><FONT face="Times New Roman" size=2>288</FONT><FONT face="Times New Roman" size=2>-</FONT><FONT face="Times New Roman" size=2>0246
(U.S.); 440</FONT><FONT face="Times New Roman" size=2>-</FONT><FONT face="Times New Roman" size=2>996</FONT><FONT face="Times New Roman" size=2>-</FONT><FONT face="Times New Roman" size=2>5682 </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>(international).
The passcode is 69664109. A live  audio</FONT><FONT face="Times New Roman" size=2>-</FONT><FONT face="Times New Roman" size=2>only
webcast is also available at  http://edge.media</FONT><FONT face="Times New Roman" size=2>-</FONT><FONT face="Times New Roman" size=2>server.com/m/p/8h3xqwwa/lan/en.
The audio webcast  of the conference call will be available for replay </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>approximately
one hour following the live broadcast through December 5,  2015.</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>About
Geron</FONT></B><B><FONT face="Times New Roman" size=2></FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Geron is a clinical stage  biopharmaceutical company focused on the
collaborative development of a first-in</FONT><FONT face="Times New Roman" size=2>-</FONT><FONT face="Times New Roman" size=2>class </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>telomerase
inhibitor,  imetelstat, in hematologic myeloid malignancies. For more information about  Geron, visit </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>www.geron.com.</FONT><FONT face="Times New Roman" size=2></FONT></P>

<P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2></FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><STRONG>Use of Forward-Looking
Statements</STRONG></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Except for the historical information contained herein, this press
release contains forward-looking statements made pursuant to the &#147;safe harbor&#148; provisions of the Private Securities
Litigation Reform Act of 1995. Investors are cautioned that statements in this press release regarding: (i) Geron&#146;s
potential receipt of development, regulatory and sales milestones, as well as royalties on potential future sales of
imetelstat commercialized under the collaboration agreement with Janssen; (ii) timing of planned and potential clinical
trials of imetelstat to be conducted under the collaboration agreement with Janssen, including the Phase 2 study in
myelofibrosis and the Phase 2 study in myelodysplastic syndromes, and other potential activities under the collaboration
agreement with Janssen; (iii) the safety and efficacy of imetelstat; (iv) Geron&#146;s desire to diversify its product
portfolio; (v) financial projections and expectations; (vi) intellectual property protection; and (vii) other statements that
are not historical facts, constitute forward-looking statements. These statements involve risks and uncertainties that can
cause actual results to differ materially from those in such forward-looking statements. These risks and
uncertainties,include, without limitation, risks and uncertainties related to: (i) the uncertain, time-consuming and
expensive product development and regulatory process, including whether Geron and Janssen will succeed in overcoming all
of the clinical safety and efficacy, technical, scientific, manufacturing and regulatory challenges in the development and
commercialization of imetelstat; (ii) the fact that Geron may not receive any milestone, royalty or other payments from
Janssen because Janssen may terminate the collaboration agreement for any reason; (iii) the ability of Geron and Janssen to
protect and maintain intellectual property rights for imetelstat; (iv) Geron&#146;s dependence on Janssen for the
development, regulatory approval, manufacture and commercialization of imetelstat, including the risks that if Janssen were
to breach or terminate the collaboration agreement or otherwise fail to successfully develop and commercialize imetelstat and
in a timely manner, or at all, Geron would not obtain the anticipated financial and other benefits of the collaboration
agreement with Janssen and the clinical development or commercialization of imetelstat could be delayed or terminated; (v)
whether imetelstat is safe and efficacious, and whether any future efficacy or safety results may cause the benefit-risk
profile of imetelstat to become unacceptable; (vi) whether imetelstat can be applied to any or to multiple hematologic
malignancies; (vii) unanticipated expenses or charges resulting from the organizational resizing; (viii) whether Geron will
obtain additional products or engage in any strategic transaction; and (ix) the need for future capital. Additional
information on the above risks and uncertainties and additional risks, uncertainties and factors that could cause
actual results to differ materially from those in the forward-looking statements are contained in Geron&#146;s periodic
reports filed with the Securities and Exchange Commission under the heading &#147;Risk Factors,&#148; including Geron&#146;s
quarterly report on Form 10-Q for the quarter ended June 30, 2015. Undue reliance should not be placed on forward-looking
statements, which speak only as of the date they are made, and the facts and assumptions underlying the forward-looking
statements may change. Except as required by law, Geron disclaims any obligation to update these forward-looking statements
to reflect future information, events or circumstances.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>CONTACT:</FONT></B><B><FONT face="Times New Roman" size=2></FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Anna Krassowska,
Ph.D.<BR></FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>Investor and Media Relations<BR></FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>650</FONT><FONT face="Times New Roman" size=2>-</FONT><FONT face="Times New Roman" size=2>473</FONT><FONT face="Times New Roman" size=2>-</FONT><FONT face="Times New Roman" size=2>7765<BR></FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>investor@geron.com<BR></FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>media@geron.com</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Financial table
follows.</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>GERON
CORPORATION<BR></FONT></B><B><FONT face="Times New Roman" size=2>CONDENSED
STATEMENTS OF OPERATIONS<BR></FONT></B><B><FONT face="Times New Roman" size=2></FONT></B><B><FONT face="Times New Roman" size=2>(UNAUDITED)</FONT></B><B><FONT face="Times New Roman" size=2></FONT></B></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="77%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="12%" colSpan=7><B><FONT face="Times New Roman" size=2>Three Months Ended</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD noWrap style="text-align: center" width="9%" colSpan=7><B><FONT face="Times New Roman" size=2>Nine Months Ended</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="77%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="12%" colSpan=7><B><FONT face="Times New Roman" size=2>September 30,</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=7><B><FONT face="Times New Roman" size=2>September 30,</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="77%"><I><FONT face="Times New Roman" size=2>(In thousands, except share and per share
    data)</FONT></I></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD NOWRAP COLSPAN="3" STYLE="text-align: center; width: 5%; border-bottom: Black 1pt solid"><B><FONT face="Times New Roman" size=2>2015</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="6%" colSpan=3><B><FONT face="Times New Roman" size=2>2014</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=2>2015</FONT></B> <FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=3><STRONG><FONT size=2 face="Times New Roman">2014</FONT></STRONG></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="77%" bgColor=#cceeff><FONT size=2 face="Times New Roman">Revenues:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="3%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="4%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="2%" bgColor=#cceeff><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="2%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="77%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collaboration
      revenue</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT size=2 face="Times New Roman">35,000</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD noWrap align=right width="4%"><FONT size=2 face="Times New Roman">&#151;</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD noWrap align=right width="2%"><FONT size=2 face="Times New Roman">35,000</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD noWrap align=right width="2%"><FONT size=2 face="Times New Roman">&#151;</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR>
    <TD noWrap align=left width="77%" bgColor=#cceeff><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;License fees and
      royalties</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#cceeff><FONT size=2 face="Times New Roman">363</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="4%" bgColor=#cceeff><FONT size=2 face="Times New Roman">160</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#cceeff><FONT size=2 face="Times New Roman">1,151</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#cceeff><FONT size=2 face="Times New Roman">975</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#cceeff></TD></TR>
  <TR>
    <TD noWrap align=left width="77%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total
      revenues</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT size=2 face="Times New Roman">35,363</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="4%"><FONT size=2 face="Times New Roman">160</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT size=2 face="Times New Roman">36,151</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT size=2 face="Times New Roman">975</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR>
    <TD noWrap align=left width="77%">&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="4%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR>
    <TD noWrap align=left width="77%" bgColor=#cceeff><FONT size=2 face="Times New Roman">Operating expenses:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="3%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="4%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="2%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="2%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="77%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and
      development</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT size=2 face="Times New Roman">4,050</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="4%"><FONT size=2 face="Times New Roman">5,994</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT size=2 face="Times New Roman">13,849</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT size=2 face="Times New Roman">16,356</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR>
    <TD noWrap align=left width="77%" bgColor=#cceeff><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring
      charges</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="3%" bgColor=#cceeff><FONT size=2 face="Times New Roman">(41</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff><FONT size=2 face="Times New Roman">)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="4%" bgColor=#cceeff><FONT size=2 face="Times New Roman">&#151;</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="2%" bgColor=#cceeff><FONT size=2 face="Times New Roman">1,306</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="2%" bgColor=#cceeff><FONT size=2 face="Times New Roman">&#151;</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD></TR>
  <TR>
    <TD noWrap align=left width="77%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and
      administrative</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT size=2 face="Times New Roman">4,334</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="4%"><FONT size=2 face="Times New Roman">4,073</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT size=2 face="Times New Roman">12,911</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT size=2 face="Times New Roman">11,920</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="77%" bgColor=#cceeff><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total
      operating expenses</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#cceeff><FONT face="Times New Roman" size=2>8,343</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="4%" bgColor=#cceeff><FONT face="Times New Roman" size=2>10,067</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#cceeff><FONT face="Times New Roman" size=2>28,066</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#cceeff><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff><FONT face="Times New Roman" size=2></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#cceeff><FONT face="Times New Roman" size=2>28,276</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#cceeff></TD></TR>
  <TR>
    <TD noWrap align=left width="77%"><FONT size=2 face="Times New Roman">Income (loss) from
      operations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT size=2 face="Times New Roman">27,020</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="4%"><FONT size=2 face="Times New Roman">(9,907</FONT></TD>
    <TD noWrap align=left width="1%"><FONT size=2 face="Times New Roman">)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT size=2 face="Times New Roman">8,085</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT size=2 face="Times New Roman">(27,301</FONT></TD>
    <TD noWrap align=left width="1%"><FONT size=2 face="Times New Roman">)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="77%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="4%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="77%" bgColor=#cceeff><FONT face="Times New Roman" size=2>Unrealized gain on derivatives</FONT><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="3%" bgColor=#cceeff><FONT face="Times New Roman" size=2>&#151;</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="4%" bgColor=#cceeff><FONT face="Times New Roman" size=2>289</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="2%" bgColor=#cceeff><FONT face="Times New Roman" size=2>16</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="2%" bgColor=#cceeff><FONT face="Times New Roman" size=2>366</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="77%"><FONT face="Times New Roman" size=2>Interest and other income</FONT><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>187</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="4%"><FONT face="Times New Roman" size=2>91</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>481</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>273</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR>
    <TD noWrap align=left width="77%" bgColor=#cceeff><FONT size=2 face="Times New Roman">Interest and other expense</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#cceeff><FONT size=2 face="Times New Roman">(22</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#cceeff><FONT size=2 face="Times New Roman">)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="4%" bgColor=#cceeff><FONT size=2 face="Times New Roman">(22</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#cceeff><FONT size=2 face="Times New Roman">)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#cceeff><FONT size=2 face="Times New Roman">(68</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#cceeff><FONT size=2 face="Times New Roman">)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#cceeff><FONT size=2 face="Times New Roman">(61</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#cceeff><FONT size=2 face="Times New Roman">)</FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="77%"><FONT size=2 face="Times New Roman">Net income (loss)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" style="padding-bottom: 1.5pt"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT size=2 face="Times New Roman">27,185</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" style="padding-bottom: 1.5pt"><FONT size=2 face="Times New Roman">$ </FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="4%"><FONT size=2 face="Times New Roman">(9,549</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT size=2 face="Times New Roman">)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" style="padding-bottom: 1.5pt"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT size=2 face="Times New Roman">8,514</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" style="padding-bottom: 1.5pt"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT size=2 face="Times New Roman">(26,723</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT size=2 face="Times New Roman">) </FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="77%">&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="4%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR>
    <TD noWrap align=left width="77%" bgColor=#cceeff><STRONG><FONT size=2 face="Times New Roman">Net income (loss) per
      share:</FONT></STRONG></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="3%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="4%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="2%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="2%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD></TR>
  <TR>
    <TD noWrap align=left width="77%"><FONT size=2 face="Times New Roman">Basic</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" style="padding-bottom: 1.5pt"><FONT size=2 face="Times New Roman">$ </FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT size=2 face="Times New Roman">0.17</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" style="padding-bottom: 1.5pt"><FONT size=2 face="Times New Roman">$ </FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="4%"><FONT size=2 face="Times New Roman">(0.06</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT size=2 face="Times New Roman">)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" style="padding-bottom: 1.5pt"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT size=2 face="Times New Roman">0.05</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" style="padding-bottom: 1.5pt"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT size=2 face="Times New Roman">(0.18</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT size=2 face="Times New Roman">)</FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="77%" bgColor=#cceeff><FONT size=2 face="Times New Roman">Diluted</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff style="padding-bottom: 1.5pt"><FONT size=2 face="Times New Roman">$ </FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#cceeff><FONT size=2 face="Times New Roman">0.17</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff style="padding-bottom: 1.5pt"><FONT size=2 face="Times New Roman">$ </FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="4%" bgColor=#cceeff><FONT size=2 face="Times New Roman">(0.06</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#cceeff><FONT size=2 face="Times New Roman">)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff style="padding-bottom: 1.5pt"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%" bgColor=#cceeff><FONT size=2 face="Times New Roman">0.05</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff style="padding-bottom: 1.5pt"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%" bgColor=#cceeff><FONT size=2 face="Times New Roman">(0.18</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#cceeff><FONT size=2 face="Times New Roman">)</FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="77%" bgColor=#cceeff>&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="3%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="4%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="2%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="2%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD></TR>
  <TR>
    <TD noWrap align=left width="77%"><STRONG><FONT size=2 face="Times New Roman">Shares used in computing net income
      (loss) per share:</FONT></STRONG></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="4%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=right width="1%"></TD></TR>
  <TR>
    <TD noWrap align=left width="77%" bgColor=#cceeff><FONT size=2 face="Times New Roman">Basic</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#cceeff><FONT size=2 face="Times New Roman">158,151,747</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="4%" bgColor=#cceeff><FONT size=2 face="Times New Roman">156,843,989</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%" bgColor=#cceeff><FONT size=2 face="Times New Roman">157,922,075</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%" bgColor=#cceeff><FONT size=2 face="Times New Roman">152,338,668</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#cceeff></TD></TR>
  <TR>
    <TD noWrap align=left width="77%"><FONT size=2 face="Times New Roman">Diluted</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT size=2 face="Times New Roman">162,669,681</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="4%"><FONT size=2 face="Times New Roman">156,843,989</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT size=2 face="Times New Roman">162,448,893</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT size=2 face="Times New Roman">152,338,668</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD></TR></TABLE><BR>
<P STYLE="text-align: center"><B><FONT face="Times New Roman" size=2>GERON  CORPORATION</FONT></B><B><FONT face="Times New Roman" size=2></FONT></B><B><FONT face="Times New Roman" size=2>
<BR>
CONDENSED
BALANCE SHEETS</FONT></B></P>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap style="text-align: center" width="8%" colSpan=2><B><FONT face="Times New Roman" size=2>September 30,</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap style="text-align: center" width="8%" colSpan=2><B><FONT face="Times New Roman" size=2>December 31,</FONT></B><FONT face="Times New Roman" size=2></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><I><FONT face="Times New Roman" size=2>(In thousands)</FONT></I><FONT face="Times New Roman" size=2></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="8%" colSpan=2><B><FONT face="Times New Roman" size=2>2015</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="8%" colSpan=2><B><FONT face="Times New Roman" size=2>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap style="text-align: center" width="8%" colSpan=2><B><FONT face="Times New Roman" size=2>(Unaudited)</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD noWrap style="text-align: center" width="8%" colSpan=2><B><FONT face="Times New Roman" size=2>(Note 1)</FONT></B><B><FONT face="Times New Roman" size=2></FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#cceeff><FONT face="Times New Roman" size=2>Current assets:</FONT><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="7%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="7%" bgColor=#cceeff><B><FONT face="Times New Roman" size=2></FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash,
      cash equivalents and restricted cash</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="7%"><FONT face="Times New Roman" size=2>17,089</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="7%"><FONT face="Times New Roman" size=2>43,062</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#cceeff><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current
      marketable securities</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="7%" bgColor=#cceeff><FONT face="Times New Roman" size=2>102,857</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="7%" bgColor=#cceeff><FONT face="Times New Roman" size=2>108,645</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
      current assets</FONT><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="7%"><FONT face="Times New Roman" size=2>2,069</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="7%"><FONT face="Times New Roman" size=2>1,699</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#cceeff><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total
      current assets</FONT><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="7%" bgColor=#cceeff><FONT face="Times New Roman" size=2>122,015</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="7%" bgColor=#cceeff><FONT face="Times New Roman" size=2>153,406</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#cceeff><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=left width="7%" bgColor=#cceeff>&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="7%" bgColor=#cceeff><FONT face="Times New Roman" size=2></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>Noncurrent marketable securities</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="7%"><FONT face="Times New Roman" size=2>31,821</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="7%"><FONT face="Times New Roman" size=2>18,932</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#cceeff><FONT face="Times New Roman" size=2>Property and equipment, net</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="7%" bgColor=#cceeff><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>183</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="7%" bgColor=#cceeff><FONT face="Times New Roman" size=2>173</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=right width="1%" style="padding-bottom: 1.5pt"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="7%"><FONT face="Times New Roman" size=2>154,019</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 style="padding-bottom: 1.5pt">$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="7%"><FONT face="Times New Roman" size=2>172,511</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="7%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="7%"><FONT face="Times New Roman" size=2></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#cceeff><FONT face="Times New Roman" size=2>Current liabilities</FONT><FONT face="Times New Roman" size=2>
      </FONT><FONT face="Times New Roman" size=2><sup>(Note 2)</sup></FONT><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="7%" bgColor=#cceeff><FONT face="Times New Roman" size=2>6,125</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="7%" bgColor=#cceeff><FONT face="Times New Roman" size=2>41,799</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>Stockholders&#146; equity</FONT><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="7%"><FONT face="Times New Roman" size=2>147,894</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="7%"><FONT face="Times New Roman" size=2>130,712</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#cceeff><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff style="padding-bottom: 2pt"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="7%" bgColor=#cceeff><FONT face="Times New Roman" size=2>154,019</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#cceeff></TD>
    <TD noWrap align=right width="1%" bgColor=#cceeff style="padding-bottom: 2pt"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="7%" bgColor=#cceeff><FONT face="Times New Roman" size=2>172,511</FONT></TD></TR></TABLE></DIV><BR>
<TABLE style="LINE-HEIGHT: NORMAL; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="1%"><FONT size=2 face="Times New Roman"><STRONG>Note 1</STRONG><FONT face="Times New Roman">:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD vAlign=top align=left width="100%"><FONT face="Times New Roman" size=2>Derived from audited financial statements
      included in the company&#146;s Annual Report on Form 10-K for the year ended
      December 31, 2014.</FONT><FONT face="Times New Roman" size=2></FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="100%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="1%"><STRONG><FONT size=2 face="Times New Roman">Note 2:</FONT></STRONG></TD>
    <TD vAlign=top align=left width="100%">
      <P align=left><FONT face="Times New Roman" size=2>Current liabilities        balance as of December 31, 2014 includes $35
      million in deferred revenue        resulting from the</FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>
      upfront       cash payment received under the        collaboration with Janssen in December 2014. The company fully </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>recognized
      the $35 million upfront payment as collaboration revenue        upon the company&#146;s transfer of the </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>imetelstat
      license        rights and completion of technology transfer</FONT><FONT face="Times New Roman" size=2>-</FONT><FONT face="Times New Roman" size=2>related
      activities in the third quarter of 2015.</FONT><FONT face="Times New Roman" size=2></FONT></P></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>###</FONT><FONT face="Times New Roman" size=2></FONT></P>
<HR align=center width="100%" noShade size="2">

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>exhibit99-1x1x1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-1x1x1.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  V &H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BOY./VO
MO^#K_P"!'P3_ &D_B#^S%^RW^Q_\=/VVO%_PC\0>*/"GQ'\1>!-9M?"WA:#7
M_!VI2Z1XB3P4=&\*?$_Q#XNT31M2MKK3]0\2W>@^&='>ZMGFTB?6-+EMM3G_
M *QB <9[<BOXL_\ @RN\-: ?V4OVW?B$VEV;^-_$?[5UOX:UOQ.\$;:SJ.@^
M'_AQX<UO2-*N;Y@9Y+.QU?Q=XDU&& OL^U:M=S,"[Y#MOY?YV _8C_@DC_P7
MG_92_P""M-]XQ^'?@CPWXT^!G[1?P\T?_A(/%GP,^)LVE76I7OA^&]BTS4_$
M/@/Q)I4D<'BW2/#^J75CIGB&*^TCPSXAT>[O[-[KP\MA<PWTGZI_M+?M'?"+
M]D7X$?$[]I'X\>*$\'?";X1^&;GQ3XQUTVMQ?W,=I'-!96.G:7IMHDEWJNN:
M[JUY8:'H.E6J-<:GK.HV-C%AYPP_B8T3P[H?P\_X/;38^"-+L_#%AXO\-^(]
M>\2V&CQ"SL]8UKQ3^P7K'B+Q'J5[:Q%87NM;\0Q)K^IR*B_:]::35)@][-+,
M_P"K?_!WC?WUI_P1O\9VUI=36\&J_M ? JQU***1DCOK*+7-4U2.UN54@30)
MJ.G6%ZL;AE%S9V\H&^)2$_U2^]I?J@V_+\O\T?#6K_\ !YU\.9Y]<\8> O\
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MF^D>.?C]\14\?P6JQLOV2[\7Z1X;TO1=3U*';>FRLK!5F']GV8B_O2\%^ ?
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M/^"TG_9*OB!_ZMS]G&O"O^#@G_E9'_X(K?[O[*7_ *V;X[KW7_@DA_RM4?\
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;KY.WX(****!A1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
